# TLR5 drives metabolic dysfunction-associated steatohepatitis through lipid- and flagellin-induced hepatocyte injury signaling

Source: [science.org](https://www.science.org/doi/abs/10.1126/sciadv.aef9541?af=R) · 2026-11-18 · Life
Page: https://themorning.science/story/tlr5-drives-metabolic-dysfunction-associated-steatohepatitis-through-lipid-and-f-3d30e496c5067f56
Kind: research · Impact: low

## In brief

- A study in Science Advances reports that TLR5 drives metabolic dysfunction-associated steatohepatitis (MASH).
- The study describes lipid- and flagellin-induced hepatocyte injury signaling as the mechanism involved.
- Only the title and citation were available, so experimental details and sample sizes are not known from the provided sources.

## Why it matters

It links the immune receptor TLR5 to liver injury in MASH, a possible new target for future research, though the provided sources contain no experimental details.

## Timeline

- 2026-11-18: Study published in Science Advances (Volume 12, Issue 47)

## Coverage

- [TLR5 drives metabolic dysfunction-associated steatohepatitis through lipid- and flagellin-induced hepatocyte injury signaling](https://www.science.org/doi/abs/10.1126/sciadv.aef9541?af=R) — science.org, 2026-11-18

Tags: tlr5, mash, steatohepatitis, hepatocytes, flagellin, liver disease

---

Brief generated by AI (claude-haiku-5-5) from the reporting listed under Coverage. Headlines belong to their publishers. The Morning Science – https://themorning.science
